Dave Hickey to Retire from Becton, Dickinson and Company as EVP and President of the Life Sciences, Effective July 1
Portfolio Pulse from Benzinga Newsdesk
Dave Hickey, EVP and President of the Life Sciences segment at Becton, Dickinson and Company (BDX), will retire effective July 1. Hickey has been with BD since 2014, holding various leadership roles.
February 27, 2024 | 11:52 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Dave Hickey's retirement from Becton, Dickinson and Company (BDX) as EVP and President of the Life Sciences may lead to short-term uncertainty.
Leadership changes, especially in high-level positions such as EVP and President of a major segment, can lead to short-term uncertainty among investors. However, given BD's history and market position, this change is likely to be managed effectively, minimizing long-term impact.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 80